First Look at HARMONi-6 Results: Dr. Monty Pal on ASCO26 Plenary Research

Dr. Monty Pal of City of Hope analyzes the results of the HARMONi-6 trial comparing ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in previously untreated advanced squamous non–small cell lung cancer. Read the full abstract (LBA4) from the 2026 ASCO Annual Meeting: https://www.asco.org/abstracts-presentations/267303 For more on ASCO26, visit https://dailynews.ascopubs.org/meetings/asco-annual-meeting _Data as of May 7, 2026_

Video Lainnya